Gem Pharmaceuticals' Grant

Gem Pharmaceuticals raised a round of funding on May 21, 2013. Investors include Idaho Commerce.

Gem Pharmaceuticals is a clinical-stage biopharmaceutical company developing anthracycline derivatives specifically designed to eliminate the critical cardiotoxicity side effect of this powerful class…

Articles about Gem Pharmaceuticals' Grant: